Yuxiang Wang
机构:Hebei Medical University, Central South University, Xidian University, China Pharmaceutical University, Tianjin University, Northeast Agricultural University, Northwestern Polytechnical University, Hunan Normal University, China Medical University, Qufu Normal University, Peking University, Huazhong Agricultural University, Taipei Veterans General Hospital, Southwest Medical University, Affiliated Hospital of Southwest Medical University, Agricultural Genomics Institute at Shenzhen, Key Laboratory of Guangdong Province, First Affiliated Hospital of Guangzhou Medical University, Shanxi Provincial Cancer Hospital, Fourth Hospital of Hebei Medical University, First Hospital of China Medical University, Education Department of Heilongjiang Province, Cancer Hospital of Chinese Academy of Medical Sciences, Peking University Third Hospital, Ministry of Agriculture, First Affiliated Hospital of Bengbu Medical College, Xiangya Hospital Central South University, State Key Laboratory of Natural Medicine, Huazhong University of Science and Technology, Case Western Reserve University, Beijing University of Chemical Technology, China Medical University, Guangzhou Medical University · ORCID:0000-0002-1049-8469
发表论文 292 篇 · 总被引 3404 次 · h-index 35
代表论文
- Bioinspired Bi-amino Acid Ce-MOFs Boosting Oxidase-like Activity: Dual-mode Aflatoxin Detection and Antimicrobial Activity Platform (2025 · Chemical Engineering Journal · 被引 15)
- Deep learning-based prediction of axillary pathological complete response in patients with breast cancer using longitudinal multiregional ultrasound (2025 · EBioMedicine · 被引 11)
- Lycopene, a natural plant extract, alleviates atrazine-induced ferroptosis in hepatocytes by activating cytochrome P450 oxidoreductase (2025 · International Journal of Biological Macromolecules · 被引 8)
- Nonlinear dynamics of intricate constrained fluid-conveying pipelines based on the global modal method (2025 · Applied Mathematics and Mechanics · 被引 6)
- Changes in accelerated aging and risk of cardiovascular disease and mortality: three cohort studies (2025 · BMC Medicine · 被引 5)
- GL‐V9 inhibits Caspase‐11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis (2025 · British Journal of Pharmacology · 被引 3)